Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Shah

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
JAMA Otolaryngology-- Head & Neck Surgery|December 4, 2025
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical TrialsLaila A Gharzai, Emily Morris, Matthew J Schipper, et al.
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.
Oral Oncology|November 2, 2022
Prognostic value of CD103<sup>+</sup> tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinomaJoshua D Smith, Emily L Bellile, Susan E Ellsperman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
JAMA Otolaryngology-- Head & Neck Surgery|December 4, 2025
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical TrialsLaila A Gharzai, Emily Morris, Matthew J Schipper, et al.
The Journal of Molecular Diagnostics : JMD|May 7, 2026
Validation of MyHPVscore: a high-performance HPV ctDNA lab developed testJordan Currie, Heather Walline, Colleen G Hochfelder, et al.
Oral Oncology|November 2, 2022
Prognostic value of CD103<sup>+</sup> tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinomaJoshua D Smith, Emily L Bellile, Susan E Ellsperman, et al.
Pageof 3